144 related articles for article (PubMed ID: 34514559)
1. The Role of Immunocytochemical Markers to Differentiate Primary from Secondary Neoplastic Hepatic Masses: A Diagnostic Challenge on Cytology.
Bhattacharya JB; Jain SL; Devi S
Turk Patoloji Derg; 2021; 37(3):196-202. PubMed ID: 34514559
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer.
Agarwal A; Handa U; Kundu R; Sachdev A; Kochhar S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S434-S438. PubMed ID: 36510999
[TBL] [Abstract][Full Text] [Related]
3. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
Ibrahim TR; Abdel-Raouf SM
Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
Onofre AS; Pomjanski N; Buckstegge B; Böcking A
Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
[TBL] [Abstract][Full Text] [Related]
7. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
Atta IS
Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
[TBL] [Abstract][Full Text] [Related]
13. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
14. [Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
Yip YC; Wang FH; Vong HT; Zhang M; Wen JM
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):626-9. PubMed ID: 22177248
[TBL] [Abstract][Full Text] [Related]
15. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver.
Labib OH; Harb OA; Khalil OH; Baiomy TA; Gertallah LM; Ahmed RZ
J Gastrointest Cancer; 2020 Mar; 51(1):88-101. PubMed ID: 30784016
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphological variables of hepatic malignancies in fine needle aspiration smears with special reference to grading of hepatocellular carcinoma.
Balani S; Malik R; Malik R; Kapoor N
J Cytol; 2013 Apr; 30(2):116-20. PubMed ID: 23833401
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Porta Hepatis Lesions: A Retrospective Study.
Jones K; Biederman L; Draganova-Tacheva R; Solomides C; Bibbo M
Acta Cytol; 2016; 60(2):154-60. PubMed ID: 27070208
[TBL] [Abstract][Full Text] [Related]
20. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
Yoder M; Zimmerman RL; Bibbo M
Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
